Mark Cleveland

1.9k total citations
37 papers, 1.5k citations indexed

About

Mark Cleveland is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Cleveland has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Surgery and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Cleveland's work include Colorectal Cancer Screening and Detection (16 papers), Gastrointestinal motility and disorders (10 papers) and Gastric Cancer Management and Outcomes (9 papers). Mark Cleveland is often cited by papers focused on Colorectal Cancer Screening and Detection (16 papers), Gastrointestinal motility and disorders (10 papers) and Gastric Cancer Management and Outcomes (9 papers). Mark Cleveland collaborates with scholars based in United States and Canada. Mark Cleveland's co-authors include John McGowan, Jack A. DiPalma, Jack A. Di Palma, Jorge L. Herrera, Peter H. DeRidder, Byron E. Kolts, Roy C. Orlando, Douglas K. Rex, Russell W. Pelham and Bruce G. Wolff and has published in prestigious journals such as Gastroenterology, Kidney International and The Journal of Pediatrics.

In The Last Decade

Mark Cleveland

36 papers receiving 1.4k citations

Peers

Countries citing papers authored by Mark Cleveland

Since Specialization

Citations

This map shows the geographic impact of Mark Cleveland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Cleveland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Cleveland more than expected).

Fields of papers citing papers by Mark Cleveland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Cleveland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Cleveland. The network helps show where Mark Cleveland may publish in the future.

Co-authorship network of co-authors of Mark Cleveland

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Cleveland. A scholar is included among the top collaborators of Mark Cleveland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Cleveland. Mark Cleveland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparative subchronic toxicity of copper and a tertiary copper mixture to early life stage rainbow trout (Oncorhynchus mykiss): impacts on growth, development, and histopathology 2023 ·Ecotoxicology ·(unknown), Laura Baseler, (unknown), Mark Cleveland, Vicki L. Marlatt	2
2	A Phase 2 evaluation of a new flavored peg and sulfate solution compared to an over-the-counter laxative, peg and sports drink bowel preparation combination 2023 ·BMC Gastroenterology ·Gregory Wiener, Peter Winkle, (unknown), Mark Cleveland, Jack A. Di Palma	1
3	Enumeration potential of environmental DNA for Pacific salmon stock assessments 2023 ·Environmental DNA ·(unknown), Michael J. Allison, (unknown), Kevin M. Koch, Jeffrey S. Anderson, Leithen K. M’Gonigle, Mark Cleveland, Caren C. Helbing, Vicki L. Marlatt	2
4	A Comparative Study of Treatment-Emergent Adverse Events Following Use of Common Bowel Preparations Among a Colonoscopy Screening Population: Results from a Post-Marketing Observational Study 2016 ·Digestive Diseases and Sciences ·Kathryn Anastassopoulos, Francis A. Farraye, Tyler Knight, Sam Colman, Mark Cleveland, Russell W. Pelham	19
5	Cost-analysis model of colonoscopy preparation using split-dose reduced-volume oral sulfate solution (OSS) and polyethylene glycol with electrolytes solution (PEG-ELS) 2015 ·Journal of Medical Economics ·Lynn Huynh, (unknown), Matthew Davis, (unknown), Mark Cleveland, Francis A. Farraye, (unknown)	8
6	A randomized, controlled trial of oral sulfate solution plus polyethylene glycol as a bowel preparation for colonoscopy 2014 ·Gastrointestinal Endoscopy ·Douglas K. Rex, John McGowan, Mark Cleveland, Jack A. Di Palma	11
7	A randomized clinical study comparing reduced-volume oral sulfate solution with standard 4-liter sulfate-free electrolyte lavage solution as preparation for colonoscopy 2010 ·Gastrointestinal Endoscopy ·Douglas K. Rex, Jack A. Di Palma, (unknown), John McGowan, Mark Cleveland	93
8	Clinical trial: single‐ and multiple‐dose pharmacokinetics of polyethylene glycol (PEG‐3350) in healthy young and elderly subjects 2008 ·Alimentary Pharmacology & Therapeutics ·Russell W. Pelham, (unknown), (unknown), Mark Cleveland, P. Stetson	44
9	PEG3350 in the Treatment of Childhood Constipation: A Multicenter, Double-Blinded, Placebo-Controlled Trial 2008 ·The Journal of Pediatrics ·Samuel Nurko, Nader N. Youssef, (unknown), Annette Langseder, John McGowan, Mark Cleveland, (unknown)	84
10	An open‐label study of chronic polyethylene glycol laxative use in chronic constipation 2007 ·Alimentary Pharmacology & Therapeutics ·Jack A. Di Palma, Mark Cleveland, John McGowan, Jorge L. Herrera	30
11	A Randomized, Multicenter, Placebo-Controlled Trial of Polyethylene Glycol Laxative for Chronic Treatment of Chronic Constipation 2007 ·The American Journal of Gastroenterology ·Jack A. DiPalma, Mark Cleveland, John McGowan, Jorge L. Herrera	152
12	A Randomized, Multicenter Comparison of Polyethylene Glycol Laxative and Tegaserod in Treatment of Patients With Chronic Constipation 2007 ·The American Journal of Gastroenterology ·Jack A. Di Palma, Mark Cleveland, John McGowan, Jorge L. Herrera	71
13	Clinical trial: an efficacy evaluation of reduced bisacodyl given as part of a polyethylene glycol electrolyte solution preparation prior to colonoscopy 2007 ·Alimentary Pharmacology & Therapeutics ·J A DiPalma, John McGowan, Mark Cleveland	35
14	Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study) 2004 ·Kidney International ·Wajeh Y. Qunibi, Robert Hootkins, (unknown), (unknown), Matthias Simon, (unknown), Russell W. Pelham, Mark Cleveland, Larry R. Muenz, David Y. He, Charles R. Nolan	152
15	Comparison of Reduced Volume Versus Four Liters Sulfate-Free Electrolyte Lavage Solutions for Colonoscopy Colon Cleansing 2003 ·The American Journal of Gastroenterology ·Jack A. DiPalma, Bruce G. Wolff, Alan P. Meagher, Mark Cleveland	108
16	Overnight Efficacy of Polyethylene Glycol Laxative 2002 ·The American Journal of Gastroenterology ·Jack A. Di Palma, Julie Smith, Mark Cleveland	43
17	A Randomized, Placebo-Controlled, Multicenter Study of The Safety and Efficacy of A New Polyethylene Glycol Laxative 2000 ·The American Journal of Gastroenterology ·Jack A. DiPalma, Peter H. DeRidder, Roy C. Orlando, Byron E. Kolts, Mark Cleveland	164
18	Calcium Acetate Control of Serum Phosphorus in Hemodialysis Patients 1991 ·American Journal of Kidney Diseases ·Michael Emmett, (unknown), (unknown), Charles R. Nolan, G Schmitt, Mark Cleveland	75
19	A low-sodium solution for gastrointestinal lavage 1990 ·Gastroenterology ·John S. Fordtran, Carol A. Santa Ana, Mark Cleveland	82
20	Comparison of an orally administered gastrointestinal lavage solution with traditional enema administration as preparation for colonoscopy in dogs 1989 ·Journal of the American Veterinary Medical Association ·Keith Richter, Mark Cleveland	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact